Entry Point Capital, LLC Humacyte, Inc. Call Options Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HUMA
# of Institutions
130Shares Held
30.8MCall Options Held
323KPut Options Held
582K-
Black Rock Inc. New York, NY7.14MShares$37.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$24.7 Million0.0% of portfolio
-
State Street Corp Boston, MA2.87MShares$15 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$9.73 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.6MShares$8.36 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $539M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...